IDEAYA Biosciences (IDYA) Announces $80M Proposed Public Offering of Common Stock

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced that it intends to offer and sell up to $80.0 million of shares of its common stock in an underwritten public offering. In addition, IDEAYA intends to grant the underwriters a 30-day option to purchase up to $12.0 million of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

J.P. Morgan, Jefferies, Citigroup and Guggenheim Securities are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Jefferies: Investment banking fees down 15% for major global banks
• DeFi Development Corp. plans $20M preferred stock offering
• Citi raises Five Below price target to $265, keeps Neutral rating